U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Over the past five years, licensing deals in the U.S. have averaged $84.8 billion. In China? Just $31.3 billion. Even with ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...